PRINCETON, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted ...
On Thursday, Anthropic announced Claude 3.5 Sonnet, its latest AI language model and the first in a new series of “3.5” models that build upon Claude 3, launched in March. Claude 3.5 can compose text, ...
Sonnet Labs has introduced a new device that enables smartphones to connect with each other without the need for network connectivity. Yes, the Sonnet lets you survive off the grids without having to ...
Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback